ContraFect Corporation announced that in connection with the Restructuring Plan, on November 15, 2023, Roger J. Pomerantz resigned as the Chief Executive Officer of the company. Dr. Pomerantz will remain a member of the Board of Directors of the Company. In connection with the Restructuring Plan, the Board appointed Michael Messinger as the Chief Executive Officer of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.016 USD | -8.57% | -11.11% | -46.67% |
May. 03 | North American Morning Briefing : Apple, Amgen -2- | DJ |
Apr. 26 | North American Morning Briefing : Tech Still in -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-46.67% | 171K | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- CFRXQ Stock
- News ContraFect Corporation
- ContraFect Corporation Announces Chief Executive Officer Changes